Perrigo Company PLC recalls EQUALINE aller-ease fexofenadine hydrochloride tablets, 180 mg, 24 HR, packaged as a) 15 count bottle, NDC 41163-571-22,
Recalled January 12, 2022 · FDA recall D-0328-2022 · Perrigo Company
Hazard
Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing. · FDA Class II
Units
55,032 units
Sold at
Nationwide in the USA
Description
Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.
Product
EQUALINE aller-ease fexofenadine hydrochloride tablets, 180 mg, 24 HR, packaged as a) 15 count bottle, NDC 41163-571-22, UPC 0 41163 48067 4; b) 70 tablets per bottle, NDC 41163-571-01, UPC 0 41163 49847 1; Made in the Czech Republic, Distributed by: UNFI Providence, RI 02908.
Manufacturer(s)
Perrigo Company PLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →